VALSCOPE
日本米国
codese.net

HAEMONETICS CORP

HAEUS
SEC EDGARで開く
売上高
$1.3B
百万USD
営業利益
$157M
百万USD
純利益
$97M
百万USD
ROE
12.2%
最新FY
EPS
$2.05
USD / 株
配当
-
USD / 株

業績推移

収益性

キャッシュフロー

財務状況

四半期業績

年度売上高純利益EPS
FY2021Q1$196M$11M$0.21
FY2021Q2$209M$48M$0.94
FY2021Q3$240M$32M$0.62
FY2021FY-$79M$1.55
FY2022Q1$229M$-4M$-0.09
FY2022Q2$240M$15M$0.29
FY2022Q3$260M$23M$0.45
FY2022FY-$43M$0.84
FY2023Q1$261M$20M$0.38
FY2023Q2$297M$33M$0.64
FY2023Q3$305M$33M$0.64
FY2023FY-$115M$2.24
FY2024Q1$311M$41M$0.80
FY2024Q2$318M$25M$0.48
FY2024Q3$336M$31M$0.61
FY2024FY$1.3B$118M$2.29
FY2025Q1$336M$38M$0.74
FY2025Q2$346M$34M$0.66
FY2025Q3$349M$37M$0.74
FY2025FY$1.4B$168M$3.31
FY2026Q1$321M$34M$0.70
FY2026Q2$327M$39M$0.81
FY2026Q3$339M$45M$0.95
FY2026FY$1.3B$97M$2.05

財務データ

指標FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
売上高--------$1.3B$1.4B$1.3B
営業利益$-44M$-19M$56M$84M$103M$90M$81M$156M$165M$222M$157M
純利益$-56M$-26M$46M$55M$77M$79M$43M$115M$118M$168M$97M
総資産$1.3B$1.2B$1.2B$1.3B$1.3B$1.8B$1.9B$1.9B$2.2B$2.5B$2.4B
純資産-----------
自己資本$722M$740M$752M$668M$587M$732M$749M$818M$960M$821M$796M
営業CF$122M$160M$220M$159M$158M$109M$172M$273M$182M$182M$293M
EPS$-1.09$-0.51$0.85$1.04$1.48$1.55$0.84$2.24$2.29$3.31$2.05
BPS$14.14$14.10$14.41$13.04$11.65$14.36$14.62$16.18$18.88$17.09$17.52
ROE-7.7%-3.6%6.1%8.2%13.0%10.9%5.8%14.1%12.2%20.4%12.2%
HAEMONETICS CORP(HAE)の業績・財務推移 | Valscope